Yüklüyor......
Botulinum Toxin A and Lower Urinary Tract Dysfunction: Pathophysiology and Mechanisms of Action
The use of onabotulinumtoxinA (BoNT-A) for the treatment of lower urinary tract diseases (LUTD) has increased markedly in recent years. The indications for BoNT-A treatment of LUTD now include neurogenic or idiopathic detrusor overactivity, interstitial cystitis/bladder pain syndrome and voiding dys...
Kaydedildi:
| Yayımlandı: | Toxins (Basel) |
|---|---|
| Asıl Yazarlar: | , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
MDPI
2016
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4848644/ https://ncbi.nlm.nih.gov/pubmed/27110822 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/toxins8040120 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|